Clarify Health, a predictive healthcare data analytics solution, raised $115 million in Series C funding.
Insight Partners led the round with Spark Capital, Concord Health Partners, HWVP, KKR, Rivas Capital, and Sigmas Group.
As part of the investment, Hilary Gosher, Managing Director at Insight Partners, and Will Reed, General Partner at Spark Capital, will be joining Clarify’s Board of Directors.
According to Clarify Health, its enterprise analytics platform transforms healthcare data into actionable insights for providers, health plans, and life sciences companies. The platform powers a set of automated, self-service business applications that enable healthcare organizations to optimize networks, improve care delivery, and manage population health.
“Clarify is defining a new paradigm in healthcare analytics – one that offers on-demand, real-world, and actionable insights, delivered via intuitive and time-saving solutions,” said Jean Drouin, MD, CEO, Clarify Health. “The legacy model of buying raw data and analyzing it with manual tools is unnecessarily cumbersome, increases costs, and drives poorer outcomes.”
Including the latest funding round, Clarify Health has raised over $200 million to date. The new funds will further scale self-service healthcare analytics cloud and business applications, the company said.
“Clarify brings to life the latent potential of deep healthcare analytics through its ability to quickly answer critical questions about patient journeys, clinical outcomes, and care coordination. The platform’s unique methods of enriching and sequencing healthcare data in the cloud, coupled with extensive machine learning, leads to precise insights at an unprecedented scale,” said Hilary Gosher, Managing Director at Insight Partners.
Healthcare Data Analytics companies secured $1.8 billion in venture capital funding in 2020. The funding increased by 13% in 2020, compared to $1.6 billion raised in 2019, according to the latest Mercom Digital Health Funding and M&A Report. Verana Health (formerly DigiSight), a healthcare technology company focused on curating and analyzing real-world clinical data, raised $100 million in new funding, bringing the company’s total to date to almost $150 million.